122 related articles for article (PubMed ID: 37920091)
1. Serum Levels of Hcy, sST2 and CA-125 in CHF Patients and Their Correlation with Cardiac Function Classification.
Ma W; Zhang P; Hu H
Heart Surg Forum; 2023 Sep; 26(5):E449-E454. PubMed ID: 37920091
[TBL] [Abstract][Full Text] [Related]
2. Serum Cat S, TSP-1, IL-11, BNP and sST2 Diagnostic and Prognostic Value in Chronic Heart Failure.
Xiang Y; Zhang Z; Xie C; Wang L; Wu Y; Zhan Y; Chen D
Altern Ther Health Med; 2022 May; 28(4):55-59. PubMed ID: 35452416
[TBL] [Abstract][Full Text] [Related]
3. Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress.
Zhang HF; Xie SL; Chen YX; Mai JT; Wang JF; Zhu WL; Zhu LG
J Transl Med; 2012 Jun; 10():120. PubMed ID: 22682001
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
[TBL] [Abstract][Full Text] [Related]
5. Correlation between serum urea nitrogen, cystatin C, homocysteine, and chronic heart failure.
Yao Z; Li G; Li G
Am J Transl Res; 2021; 13(4):3254-3261. PubMed ID: 34017496
[TBL] [Abstract][Full Text] [Related]
6. The association between levels of serum homocysteine and chronic heart failure: A protocol for systematic review and meta-analysis.
Wang X; Wang F; Feng Z; Cai J; Liu J
Medicine (Baltimore); 2021 Feb; 100(5):e24117. PubMed ID: 33592862
[TBL] [Abstract][Full Text] [Related]
7. Expression and Clinical Significance of Serum sST2, BDNF, CTnI, and BUN/Cr in Patients With Heart Failure.
Xie C; Zhan Y; Wu Y; Zhang Z; Xiang Y; Wang L; Chen D
Altern Ther Health Med; 2023 Jan; 29(1):176-181. PubMed ID: 36074967
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease.
May HT; Alharethi R; Anderson JL; Muhlestein JB; Reyna SP; Bair TL; Horne BD; Kfoury AG; Carlquist JF; Renlund DG
Cardiology; 2007; 107(3):178-84. PubMed ID: 16940722
[TBL] [Abstract][Full Text] [Related]
9. Levels of Serum IGF-1, HCY, and Plasma BNP in Patients with Chronic Congestive Heart Failure and Their Relationship with Cardiac Function and Short-Term Prognosis.
Hu Z; Mao L; Wang L
Evid Based Complement Alternat Med; 2022; 2022():4118976. PubMed ID: 36051497
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study.
Min Z; Xuelu L; Ran Z; Qiuhong S; Yong M
Adv Ther; 2022 Dec; 39(12):5514-5529. PubMed ID: 36224325
[TBL] [Abstract][Full Text] [Related]
11. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.
Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA
Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure.
Yin DC; Wang ZJ; Guo S; Xie HY; Sun L; Feng W; Qiu W; Qu XF
BMC Cardiovasc Disord; 2014 Apr; 14():50. PubMed ID: 24725657
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review.
Herrmann W; Herrmann M; Joseph J; Tyagi SC
Clin Chem Lab Med; 2007; 45(12):1633-44. PubMed ID: 18067448
[TBL] [Abstract][Full Text] [Related]
15. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
[TBL] [Abstract][Full Text] [Related]
16. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
17. Single sST2 protein measurement predicts adverse outcomes at 1-year follow-up in patients with chronic heart failure.
Sobczak S; Wojtczak-Soska K; Ciurus T; Sakowicz A; Pietrucha T; Lelonek M
Pol Arch Med Wewn; 2014; 124(9):452-8. PubMed ID: 25041760
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
Zhang J; Wang L; Zhao Z; Li L; Xia Y
J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine in Chronic Heart Failure.
Fournier P; Fourcade J; Roncalli J; Salvayre R; Galinier M; Caussé E
Clin Lab; 2015; 61(9):1137-45. PubMed ID: 26554232
[TBL] [Abstract][Full Text] [Related]
20. Soluble ST2 protein and hospitalizations due to worsening chronic heart failure during a one-year follow-up in a population with reduced ejection fraction.
Wojtczak-Soska K; Sakowicz A; Pietrucha T; Janikowski K; Lelonek M
Adv Clin Exp Med; 2017 Sep; 26(6):931-938. PubMed ID: 29068593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
